← All stocks

Adicet Bio, Inc.

ACET Net buying
CIK 0001720580 #4407 in the set updated 18 Sep 2026
Bought (120 mo)
$51.84M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.68M
$0.00 on a plan · $352.95K straight out of an exercise
Sold at will
$16.32M
72 of 77 sales
Net
+$35.16M
+$35.52M against sales at will

By person

22 insiders · 107 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ORBIMED ADVISORS LLC entity
10% owner
$22.33M (10)
$674.85K (4)
+$21.65M
902,885
$5.89M
GORDON CARL L
Director
$9.33M (7)
+$9.33M
2,170,670
$14.15M
SILVERSTEIN JONATHAN
Director
$8.00M (1)
+$8.00M
4,830,387
$31.49M
Sinclair Andrew
Director
$7.00M (1)
+$7.00M
3,799,142
$24.77M
+15.8%
PureTech Health LLC entity
10% owner
$3.50M (1)
$9.29M (6)
−$5.79M
2,119,696
$13.82M
+12.4%
Schor Chen
President & CEO
$68.70K (5)
$4.89M (36)
−$4.82M
140,125
$913.61K
−92.8%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$1.60M (3)
+$1.60M
932,624
$6.08M
−2.8%
Jakobovits Aya
Director
$799.48K (18)
−$799.48K
1,345,055
$8.77M
+187.1%
Aftab Blake
Chief Scientific Officer
$564.04K (6)
−$564.04K
2,981
$19.44K
Galimi Francesco
SVP & Chief Medical Officer
$327.60K (4) scheduled
−$327.60K
101,801
$663.74K
Healey Don
Chief Technology Officer
$117.80K (2)
−$117.80K
3,452
$22.51K
DUBIN STEVE
Director
$12.00K (1)
+$12.00K
22,700
$148.00K
Kauffman Michael
Director
$8.44K (1)
−$8.44K
5,900
$38.47K
Mannick Joan
Chief Medical Officer
2,004,585
$13.07M
+6.3%
Schindel Yair Chaim
Director
1,104,460
$7.20M
Chimovits Erez
Director
902,885
$5.89M
Klickstein Lloyd
Chief Medical Officer
108,566
$707.85K
+1,626%
Chodakewitz Jeffrey
Director
17,700
$115.40K
MCCABE JOHN J
Vice President, Finance
12,867
$83.89K
Peng Katie
Director
11,800
$76.94K
Sanna Bastiano
Director
5,900
$38.47K
Harvey Brian Nicholas
Chief Financial Officer
5,145
$33.55K

No percentages here. This company's share count has moved by a factor of 16.4 over the window, from 9,361,490 to 153,255,581 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
ORBIMED ADVISORS LLC
8 Apr 2026
10% owner
Sell indirect
40,416
$6.52
$263.51K
ORBIMED ADVISORS LLC
8 Apr 2026
10% owner
Sell indirect
32,523
$6.29
$204.57K
ORBIMED ADVISORS LLC
7 Apr 2026
10% owner
Sell indirect
2,400
$6.38
$15.31K
ORBIMED ADVISORS LLC
7 Apr 2026
10% owner
Sell indirect
29,319
$6.53
$191.45K
Kauffman Michael
5 Jun 2024
Director
Sell
5,900
$1.43
$8.44K
Schor Chen
29 Sep 2023
President & CEO
Sell
5,500
$1.36
$7.48K
Schor Chen
28 Sep 2023
President & CEO
Sell indirect
5,500
$1.42
$7.81K
Healey Don
15 Feb 2023
Chief Technology Officer
Sell
4,533
$7.57
$34.33K
Healey Don
10 Feb 2023
Chief Technology Officer
Sell
10,467
$7.98
$83.48K
Schor Chen
10 Nov 2022
President & CEO
Sell indirect
30,000
$20.06
$601.92K
Schor Chen
10 Nov 2022
President & CEO
Sell
9,955
$21.03
$209.32K
Aftab Blake
10 Nov 2022
Chief Scientific Officer
Sell
6,967
$21.00
$146.31K
Schor Chen
7 Nov 2022
President & CEO
Sell indirect
30,000
$19.05
$571.49K
Schor Chen
3 Nov 2022
President & CEO
Sell indirect
24,813
$18.04
$447.72K
Schor Chen
2 Nov 2022
President & CEO
Sell indirect
500
$18.00
$9.00K
Aftab Blake
19 Oct 2022
Chief Scientific Officer
Sell
8,067
$16.27
$131.25K
Schor Chen
14 Sep 2022
President & CEO
Sell indirect
952
$18.00
$17.14K
Schor Chen
13 Sep 2022
President & CEO
Sell indirect
3,371
$18.01
$60.71K
Schor Chen
12 Sep 2022
President & CEO
Sell indirect
200
$18.00
$3.60K
Schor Chen
12 Sep 2022
President & CEO
Sell indirect
66,747
$16.77
$1.12M
Schor Chen
9 Sep 2022
President & CEO
Sell indirect
8,094
$16.51
$133.60K
Aftab Blake
3 Aug 2022
Chief Scientific Officer
Sell
6,968
$18.00
$125.42K
Aftab Blake
1 Aug 2022
Chief Scientific Officer
Sell
6,968
$16.64
$115.95K
Aftab Blake
5 Jul 2022
Chief Scientific Officer
Sell
1,363
$14.50
$19.76K
Jakobovits Aya
9 Mar 2022
Director
Sell indirect
2,000
$14.00
$28.00K
Jakobovits Aya
9 Mar 2022
Director
Sell indirect
2,000
$14.00
$28.00K
Jakobovits Aya
16 Feb 2022
Director
Sell indirect
2,000
$14.83
$29.66K
Jakobovits Aya
16 Feb 2022
Director
Sell indirect
2,000
$14.83
$29.66K
Jakobovits Aya
9 Feb 2022
Director
Sell indirect
4,000
$14.03
$56.12K
Jakobovits Aya
9 Feb 2022
Director
Sell indirect
4,000
$14.03
$56.12K
Jakobovits Aya
5 Jan 2022
Director
Sell indirect
2,000
$16.90
$33.80K
Jakobovits Aya
5 Jan 2022
Director
Sell indirect
2,000
$16.93
$33.86K
Jakobovits Aya
3 Jan 2022
Director
Sell indirect
6,000
$18.02
$108.13K
Jakobovits Aya
3 Jan 2022
Director
Sell indirect
6,000
$18.02
$108.12K
Schor Chen
16 Jun 2021
President & CEO
Sell indirect
8,982
$10.53
$94.61K
Schor Chen
16 Jun 2021
President & CEO
Sell indirect
7,484
$10.53
$78.83K
Jakobovits Aya
15 Jun 2021
Director
Sell indirect
1,923
$11.16
$21.45K
Jakobovits Aya
15 Jun 2021
Director
Sell indirect
1,924
$11.16
$21.47K
Schor Chen
3 Jun 2021
President & CEO
Sell indirect
8,982
$12.06
$108.28K
Schor Chen
3 Jun 2021
President & CEO
Sell indirect
7,484
$12.06
$90.22K
Jakobovits Aya
20 May 2021
Director
Sell indirect
900
$14.23
$12.81K
Jakobovits Aya
20 May 2021
Director
Sell indirect
892
$14.23
$12.69K
Schor Chen
19 May 2021
President & CEO
Sell indirect
733
$13.73
$10.06K
Schor Chen
19 May 2021
President & CEO
Sell indirect
8,249
$13.42
$110.73K
Schor Chen
19 May 2021
President & CEO
Sell indirect
612
$13.73
$8.40K
Schor Chen
19 May 2021
President & CEO
Sell indirect
6,872
$13.42
$92.24K
Jakobovits Aya
18 May 2021
Director
Sell indirect
3,100
$14.06
$43.57K
Jakobovits Aya
18 May 2021
Director
Sell indirect
3,108
$14.05
$43.68K
Jakobovits Aya
12 May 2021
Director
Sell indirect
5,000
$13.24
$66.20K
Jakobovits Aya
12 May 2021
Director
Sell indirect
5,000
$13.23
$66.13K
Schor Chen
5 May 2021
President & CEO
Sell indirect
3,670
$14.70
$53.95K
Schor Chen
5 May 2021
President & CEO
Sell indirect
5,312
$13.90
$73.81K
Schor Chen
5 May 2021
President & CEO
Sell indirect
3,058
$14.70
$44.95K
Schor Chen
5 May 2021
President & CEO
Sell indirect
4,426
$13.90
$61.50K
Schor Chen
20 Apr 2021
President and CEO
Sell indirect
7,484
$12.01
$89.85K
Schor Chen
20 Apr 2021
President and CEO
Sell indirect
8,982
$12.01
$107.83K
Schor Chen
6 Apr 2021
President and CEO
Sell indirect
7,484
$13.04
$97.58K
Schor Chen
6 Apr 2021
President and CEO
Sell indirect
8,982
$13.04
$117.12K
Schor Chen
30 Mar 2021
President and CEO
Sell indirect
4,500
$13.22
$59.49K
Schor Chen
30 Mar 2021
President and CEO
Sell indirect
5,400
$13.22
$71.39K
Schor Chen
30 Mar 2021
President and CEO
Sell indirect
2,984
$12.30
$36.70K
Schor Chen
30 Mar 2021
President and CEO
Sell indirect
3,582
$12.30
$44.06K
Schor Chen
16 Mar 2021
President and CEO
Sell indirect
2,089
$15.66
$32.71K
Schor Chen
16 Mar 2021
President and CEO
Sell indirect
2,508
$15.07
$37.80K
Schor Chen
16 Mar 2021
President and CEO
Sell indirect
5,395
$15.66
$84.49K
Schor Chen
16 Mar 2021
President and CEO
Sell indirect
6,474
$15.07
$97.56K
PureTech Health LLC
18 Dec 2019
10% owner
Sell
6,161,531
$1.20
$7.39M
PureTech Health LLC
13 Dec 2019
10% owner
Sell
205,763
$1.24
$255.80K
PureTech Health LLC
12 Dec 2019
10% owner
Sell
385,884
$1.25
$482.32K
PureTech Health LLC
11 Dec 2019
10% owner
Sell
59,921
$1.25
$74.90K
PureTech Health LLC
10 Dec 2019
10% owner
Sell
336,561
$1.26
$423.66K
PureTech Health LLC
15 Nov 2019
10% owner
Sell
531,040
$1.25
$661.94K

What was left out

Form 4 filings counted 246
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 72
Transactions with no price 0
Shares from compensation/vesting 39,657,597
Sales filed before the plan box existed 65
History held since 30 Jan 2018